tiprankstipranks
Trending News
More News >
Cellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
PremiumRatingsCellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
2M ago
Cellectis price target lowered to $4 from $5 at Barclays
Premium
The Fly
Cellectis price target lowered to $4 from $5 at Barclays
2M ago
Cellectis Reports Q1 2025 Financial Results and Strategic Progress
Premium
Company Announcements
Cellectis Reports Q1 2025 Financial Results and Strategic Progress
2M ago
Cellectis Unveils Gene Editing Innovations at ASGCT Meeting
PremiumCompany AnnouncementsCellectis Unveils Gene Editing Innovations at ASGCT Meeting
2M ago
Cellectis S.A. Updates UCART Pipeline with Phase 2 Trial Details
Premium
Company Announcements
Cellectis S.A. Updates UCART Pipeline with Phase 2 Trial Details
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
Cellectis Unveils Innovative ‘Smart CAR T’ Strategy to Boost Solid Tumor Therapy
PremiumCompany AnnouncementsCellectis Unveils Innovative ‘Smart CAR T’ Strategy to Boost Solid Tumor Therapy
5M ago
Iovance Biotherapeutics (IOVA) Forecasts Strong Growth Due to Flagship Treatment
Premium
Market News
Iovance Biotherapeutics (IOVA) Forecasts Strong Growth Due to Flagship Treatment
5M ago
Cellectis files to sell 44M ordinary shares for holders
Premium
The Fly
Cellectis files to sell 44M ordinary shares for holders
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100